Search Results 461-470 of 30801 for Ovarian
A Study Of Epilepsy, Changes In Hormones, And Ovarian Function During Menopause (ECHO) · Overview · Participation eligibility · Participating Mayo Clinic locations.
Hope for ovarian cancer: New immunotherapy target featured image. Cancer. Hope for ovarian cancer: New immunotherapy target. Colette Gallagher. February 19 ...
... ovarian suppression and hormone therapy, and another group without chemotherapy but with ovarian suppression and hormone therapy. The study aims to ...
Three cancers — ovarian epithelial cancer, fallopian tube cancer and primary peritoneal cancer — are commonly called[...] Latest stories. Healthcare innovators ...
Mayo Clinic researchers have found a new immunotherapy target called a cryptic antigen that may be key in helping the immune system fight tumors in ovarian ...
Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal ...
... ovarian insufficiency, Hypothyroidism, Polycystic ovary syndrome, Amenorrhea ... Ovarian cyst, Ovarian cancer, Peritoneal cancer, Vulvar cancer ...
Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer. Print details. Share ...
Mayo Clinic researchers have uncovered specific microbial signatures linked to endometrial and ovarian cancers and are working toward developing innovative home ...
The purpose of this study is to evaluate AVB-S6-500 in combination with paclitaxel (Pac) in patients with platinum resistant recurrent ovarian cancer to compare ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.